Jump directly to
Jump directly to the main content
Jump directly to the search
Bayer Half-Year Financial Report Q2
2026
Wechsele die Sprache zu: Deutsch
Deutsch
de
Open search
Open main navigation
Close main navigation
Main menu
Interim Group Management Report
Interim Group Management Report
Key Events
Sales, Earnings and Financial Position
Sales, Earnings and Financial Position
Earnings Performance
Business Development by Division
Business Development by Division
Crop Science
Pharmaceuticals
Consumer Health
Financial Position
Research, Development, Innovation
Research, Development, Innovation
Crop Science
Pharmaceuticals
Consumer Health
Leaps by Bayer
Report on Future Perspectives and on Opportunities and Risks
Report on Future Perspectives and on Opportunities and Risks
Future Perspectives
Opportunities and Risks
Condensed Consolidated Interim Financial Statements
Condensed Consolidated Interim Financial Statements
Condensed Consolidated Income Statements
Condensed Consolidated Statements of Comprehensive Income
Condensed Consolidated Statements of Financial Position
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Changes in Equity
Notes to the Condensed Consolidated Interim Financial Statements
Notes to the Condensed Consolidated Interim Financial Statements
Explanatory Notes
Contingent Liabilities
Legal Risks
Notes to the Statements of Cash Flows
Related Parties
Other Information
Events After the End of the Reporting Period
Additional information
Additional information
Responsibility Statement
Report on Review of Interim Financial Information
Financial Calendar
Reporting Principles
Downloads
bayer.com
Other reports
Show more reports
Home
Search
Search
